| Financial Year |
March 31 2023 |
| Monetary Funds |
368,015,352.15 |
| Held-for-trading Financial Assets |
10,000,000.00 |
| Notes Receivable |
17,622,799.53 |
| Accounts Receivable |
344,748,193.77 |
| Advances to Suppliers |
137,924,696.96 |
| Other Receivables |
22,295,447.03 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,090,801,870.85 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
19,840,629.47 |
| Total Current Assets |
3,088,110,584.29 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
81,290,616.52 |
| Investment Properties |
18,394,259.97 |
| Fixed Assetes |
187,751,806.75 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
20,491,970.47 |
| R&D expenses |
9,160,842.67 |
| Goodwill |
178,692,839.97 |
| Long-Term Deferred and Prepaid Expenses |
9,067,925.41 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
12,084,132.72 |
| Sub-Total of Non-Current Assets |
608,267,592.35 |
| Total Assets |
3,696,378,176.64 |
| Short-Term Loans |
312,360,904.32 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
296,909,380.52 |
| Accounts Received In Advance |
162,000.00 |
| Employee Compensation Payable |
25,277,319.32 |
| Taxes Payable |
102,590,329.73 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
29,993,615.73 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
53,898,726.87 |
| Other Current Liabilities |
29,339,087.21 |
| Sub-Total of Current Liabilities |
969,567,188.83 |
| Long-term Loans |
1,141,166,730.65 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
7,477,245.31 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,169,387,320.75 |
| Total Liabilities |
2,138,954,509.58 |
| Paid-In Capital(Or Share Stock) |
495,511,725.00 |
| Capital Surplus |
787,639,752.32 |
| Surplus Reserve |
88,596,486.36 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
148,027,729.72 |
| Minority Stockholder's Interest |
47,860,407.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,509,563,260.06 |
| Owner's Equity（Stockholder's Equity） |
1,557,423,667.06 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,696,378,176.64 |
